Related references
Note: Only part of the references are listed.A phase II study evaluating the safety and efficacy of an adenovirus-DLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
W. K. Chia et al.
ANNALS OF ONCOLOGY (2012)
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
Emanuela Romano et al.
BLOOD (2012)
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
Osama E. Rahma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
Christina S. Chu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Clinical Application of a Dendritic Cell Vaccine Raised Against Heat-Shocked Glioblastoma
X. Jie et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
Nourredine Himoudi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
Fabian Benencia et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
Shinichi Fujiwara et al.
JOURNAL OF IMMUNOTHERAPY (2012)
A Novel Dendritic Cell-based Immunization Approach for the Induction of Durable Th1-polarized Anti-HER-2/neu Responses in Women With Early Breast Cancer
Gary K. Koski et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma - Phase II study results
L. Zahradova et al.
NEOPLASMA (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate
Toshio Kitawaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
W. Joost Lesterhuis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers
Goki Shindo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
Runbo Zhong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
Mitsuru Sakakibara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
Robert M. Prins et al.
CLINICAL CANCER RESEARCH (2011)
Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells
Raquel Aguilera et al.
CLINICAL CANCER RESEARCH (2011)
Peptide-Loaded Langerhans Cells, Despite Increased IL15 Secretion and T-Cell Activation In Vitro, Elicit Antitumor T-Cell Responses Comparable to Peptide-Loaded Monocyte-Derived Dendritic Cells In Vivo
Emanuela Romano et al.
CLINICAL CANCER RESEARCH (2011)
Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2011)
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma
J. C. Steele et al.
GENE THERAPY (2011)
Autologous Peripheral Blood Mononuclear Cell Recognition of Autologous Proliferating Tumor Cells in the Context of a Patient-Specific Vaccine Trial
A. N. Cornforth et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Chen-Nen Chang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
Immunotherapy for Ovarian Cancer: What's Next?
Lana E. Kandalaft et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
Mauricio W. Perroud et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients
Carlos Alfaro et al.
JOURNAL OF IMMUNOLOGY (2011)
Induction of Cellular Immune Responses in Patients With Stage-I Multiple Myeloma After Vaccination With Autologous Idiotype-pulsed Dendritic Cells
Christoph Roellig et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy
Camilo E. Fadul et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
Soyoung Baek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Tumour-loaded α-type 1-polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia Produce a Superior NK-, NKT- and CD8+ T Cell-attracting Chemokine Profile
Karin Gustafsson et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2
J. Bjoern et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Toll-Like Receptor Agonists Are They Good Adjuvants?
Sacha Gnjatic et al.
CANCER JOURNAL (2010)
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
Laura Ridolfi et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
Joannes F. M. Jacobs et al.
CLINICAL CANCER RESEARCH (2010)
Enhancement of dendritic cells as vaccines for cancer
Meghan E. Turnis et al.
IMMUNOTHERAPY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
Massimo Di Nicola et al.
BLOOD (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2009)
A Phase I Trial of Immunotherapy with Lapuleucel-T (APC8024) in Patients with Refractory Metastatic Tumors that Express HER-2/neu
Prema P. Peethambaram et al.
CLINICAL CANCER RESEARCH (2009)
Cellular immunotherapy for ovarian cancer
Martin J. Cannon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Functional specializations of human epidermal langerhans cells and CD14+ dermal dendritic cells
Eynav Klechevsky et al.
IMMUNITY (2008)
CD8+ T cell efficacy in vaccination and disease
Victor Appay et al.
NATURE MEDICINE (2008)
Dendritic cells: Understanding immunogenicity
Ralph M. Steinman
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients
Thierry Lesimple et al.
CLINICAL CANCER RESEARCH (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides
LH Butterfield et al.
CLINICAL CANCER RESEARCH (2006)
Mannan-MUC1 - Pulsed dendritic cell immunotherapy: A phase I trial in patients with adenocarcinoma
BE Loveland et al.
CLINICAL CANCER RESEARCH (2006)
Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response
AM Ercolini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dendritic cells in vaccination therapies of human malignant disease
VL Reichardt et al.
BLOOD REVIEWS (2004)
Characterization of human blood dendritic cell subsets
KPA MacDonald et al.
BLOOD (2002)
Dendritic cells injected via different routes induce immunity in cancer patients
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
